Episode

Advancing Care in Myeloproliferative Neoplasms (MPNs)

Podcast: Treating Blood Cancers
Published: May 29, 2025
Duration seconds: 1971
Processing state: not_requested
Canonical source: https://treatingbloodcancers.org/e102/?utm_source=rss&utm_medium=rss&utm_campaign=e102
Audio: https://media.blubrry.com/treating_blood_cancers/content.blubrry.com/treating_blood_cancers/TBC_E102-Dr_Gerds-MPNs_mixdown_Production.mp3
JSON: /v1/public/podcasts/treating-blood-cancers-14318/episodes/advancing-care-in-myeloproliferative-neoplasms-mpns
Markdown: /podcast/treating-blood-cancers-14318/advancing-care-in-myeloproliferative-neoplasms-mpns.md

Actions

POST https://stenobird.com/v1/public/podcasts/treating-blood-cancers-14318/episodes/advancing-care-in-myeloproliferative-neoplasms-mpns/transcription-requests
Idempotently request low-priority transcript generation for this episode.
GET https://stenobird.com/podcast/treating-blood-cancers-14318/advancing-care-in-myeloproliferative-neoplasms-mpns.md
Read the agent-friendly Markdown representation of this episode resource.

Summary

Aaron Gerds, MD, MS, Cleveland Clinic, Cleveland, OH Recorded on May 13, 2025 Aaron Gerds, MD, MS Associate Professor of Medicine Cleveland Clinic Lerner College of Medicine Case Western Reserve University School of Medicine Medical Director Case Comprehensive Cancer Center Clinical Research Office Cleveland, OH In this episode, Dr. Aaron Gerds from the Cleveland Clinic explores the intricacies of Myeloproliferative Neoplasms (MPNs), from diagnosis and monitoring to treatment goals and the latest therapeutic advances. Dr. Gerds discusses emerging therapies, the significance of clinical trials, strategies for managing side effects and long-term effects, and valuable resources for healthcare professionals, patients, and families. Tune in today for expert insights on MPNs! This episode is supported by GSK plc and Karyopharm Therapeutics.